Viewing nowMontelukast Sodium Orally Disintegrating Tablets 4mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Orally disintegrating Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

MFDS item code 201005127 · Notified 2010.08.24 · Insurance code 642903940
Prevention of asthma and relief of allergic rhinitis symptoms
This medication helps prevent asthma and manage it continuously. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis.
This medication should be taken once a day, with asthma patients taking it in the evening and allergic rhinitis patients determining the time of administration based on their condition. Patients who have both asthma and allergic rhinitis should take 1 tablet once daily in the evening. The 4 mg orally disintegrating tablet should be taken 1 hour before meals or 2 hours after meals.
For children aged 2 to 5 years, place 4 mg of montelukast on the tongue once a day and allow it to dissolve without water. This medication should be taken 1 hour before meals or 2 hours after meals.
This medication contains the artificial sweetener aspartame, which should not be used by patients with phenylketonuria, a genetic disorder. Care should be taken to ensure that the intake of aspartame does not exceed the recommendations set by WHO, and should not exceed 2.4 grams per day for adults. Individuals who have hypersensitivity to this medication should not take it, and those with lactose intolerance or certain genetic conditions should also avoid its use. Caution is necessary as various adverse reactions such as fatigue, headache, fever, abdominal pain, and rash may occasionally occur in users of different ages, including asthma and allergic rhinitis patients. Especially, if any neuropsychiatric symptoms or behavioral changes occur while taking this medication, consult a doctor immediately. During an acute asthma attack, this medication is not an immediate treatment, so emergency medications should always be carried. Patients who have hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should not take these medications while taking this drug. Pregnant or nursing women must consult a doctor regarding the use of this medication and it should only be administered if necessary. For children, safety and efficacy may vary by age, so the recommended dosage and usage by age should be strictly followed. This medication is sensitive to light, so it should be taken immediately after opening, and stored out of reach of children. There is no specific antidote for overdose; treatment should be symptomatic and according to a doctor's guidance. Do not arbitrarily reduce or discontinue other asthma treatments while taking this medication; this should always be done according to a doctor's recommendations.
Hives, severe swelling (edema), angioedema, chest tightness, breathing difficulty, cold sweat, pallor, toxic epidermal necrolysis, Stevens-Johnson syndrome, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, respiratory problems, yellowing of the skin or eyes (jaundice), extreme lethargy, liver dysfunction (jaundice), sudden and severe headache, thunderclap headache, seizures, confusion, vision changes
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and should be kept away from direct sunlight or strong light. The storage temperature should be maintained between 1 and 30 degrees Celsius.
Biconvex oval orally disintegrating tablet, white to light yellow
28 tablets/box [(7 tablets/Alu-Alu) x 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 4.16mg
Orally disintegrating Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.